As we continue to move into 2023, there are several exciting new developments that have implications for adult vaccine availability, coverage, and access. These include not only the new policy changes included in the Inflation Reduction Act of 2022 (IRA) that expand and improve adult vaccine coverage for Medicare and Medicaid beneficiaries, but also the promise of new advancements in vaccine innovation for diseases such as respiratory syncytial virus (RSV).